December 18, 2024 - 00:36

MIAMI -- In a positive development for the Miami Marlins, left-handed pitcher Jesús Luzardo has announced that he is fully healthy and actively participating in his offseason training regimen. Speaking at a community event hosted by the Marlins Foundation, Luzardo expressed his enthusiasm about his recovery progress.
"I've been able to go through my normal offseason progression: throwing, running, starting to get off the mound," he shared, highlighting his commitment to returning to peak performance. Luzardo's recovery comes after a challenging season, and his current state is a welcome relief for both the player and the team's fans.
As Luzardo continues to build his strength and refine his skills, the Marlins are optimistic about his contributions in the upcoming season. His ability to throw without limitations is a promising sign, and the team is eager to see how he will impact their pitching rotation moving forward. Fans are hopeful that Luzardo's return to form will bolster the Marlins' chances in the competitive league.
June 25, 2026 - 03:04
Houston Methodist receives $110M donation, largest in health system’s historyHouston Methodist has received a $110 million gift from The Brockman Medical Research Foundation, marking the largest single donation in the health system`s history. The funds are designated to...
June 24, 2026 - 07:18
Reproductive Health and Constitutionalism in Latin America: A Research AgendaVeronica Undurraga, a professor at the Faculty of Law of Universidad Adolfo Ibanez, has put forward a new research agenda examining the intersection of reproductive health and constitutionalism...
June 23, 2026 - 21:10
Trump administration charges 455 people, including doctors, with $6.5 billion in healthcare fraudThe Justice Department announced charges on Tuesday against 455 individuals, including dozens of doctors, for their alleged roles in healthcare fraud schemes and opioid abuse totaling 6.5 billion...
June 23, 2026 - 04:50
Federal health agencies unveil plan to speed up phase 1 clinical trials by 6 to 12 monthsAs the biotech industry gathers in San Diego for the BIO International Convention, the Department of Health and Human Services has released a series of initiatives aimed at accelerating early-stage...